Chargement en cours...

Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is considered to be a hepatic manifestation of metabolic syndrome, and its incidence is rapidly increasing worldwide. It is currently the most common chronic liver disease. NASH can progress to liver cirrhosis and hepatocel...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:World J Gastroenterol
Auteurs principaux: Takahashi, Yoshihisa, Sugimoto, Keiichiro, Inui, Hiroshi, Fukusato, Toshio
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Inc 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4385525/
https://ncbi.nlm.nih.gov/pubmed/25852263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i13.3777
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!